Topiramate-induced renal tubular acidosis

被引:17
作者
Izzedine, H [1 ]
Launay-Vacher, V [1 ]
Deray, G [1 ]
机构
[1] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
关键词
D O I
10.1016/j.amjmed.2003.08.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:281 / 282
页数:2
相关论文
共 7 条
[1]   Topiramate as an inhibitor of carbonic anhydrase isoenzymes [J].
Dodgson, SJ ;
Shank, RP ;
Maryanoff, BE .
EPILEPSIA, 2000, 41 :S35-S39
[2]   Topiramate-induced metabolic acidosis: report of two cases [J].
Ko, CH ;
Kong, CK .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (10) :701-704
[3]   An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action [J].
Shank, RP ;
Gardocki, JF ;
Streeter, AJ ;
Maryanoff, BE .
EPILEPSIA, 2000, 41 :S3-S9
[4]   Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy [J].
Stowe, CD ;
Bolliger, T ;
James, LP ;
Haley, TM ;
Griebel, ML ;
Farrar, HC .
PHARMACOTHERAPY, 2000, 20 (01) :105-109
[5]   Efficacy and safety of topiramate in refractory epilepsy: A long-term prospective trial [J].
Tartara, A ;
Sartori, I ;
Manni, R ;
Galimberti, CA ;
DiFazio, M ;
Perucca, E .
ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 17 (06) :429-432
[6]  
WEINER I M, 1990, P713
[7]   Topiramate and metabolic acidosis [J].
Wilner, A ;
Raymond, K ;
Pollard, R .
EPILEPSIA, 1999, 40 (06) :792-795